Therapies directed at the basic defect in cystic fibrosis

Clinics in Chest Medicine

Volumn 19, Issue 3, 1998, Pages 515-525

  Zeitlin, P L ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; AMRINONE; BUTYRIC ACID DERIVATIVE; CHLORIDE CHANNEL; GENISTEIN; GENTAMICIN; MILRINONE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

CHLORIDE TRANSPORT; CLINICAL TRIAL; CYSTIC FIBROSIS; GENE MUTATION; GENE THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN SYNTHESIS INHIBITION; REVIEW;

EID: 0031717590     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70097-6     Document Type: Article

References (84)

1. S.A. Afione C.K. Conrad W.G. Kearns In vivo model of adeno-associated virus vector persistence and rescue J Virol 70 1996 3235 3241
2. M.L. Batshaw S.W. Brusilow Evidence of lack of toxicity of sodium phenylacetate and sodium benzoate in treating urea cycle enzymopathies J Inherit Metab Dis 4 1981 231
3. G. Bellon L. Michel-Calemard D. Thouvenot Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial Hum Gene Ther 8 1997 15 25
4. B.A. Berkowitz C.L. Bevins M.A. Zasloff Magainins: A new family of membrane-active host defense peptides Biochem Pharmacol 39 1990 625 629
5. R.C. Boucher M.R. Knowles L.G. Johnson Gene therapy for cystic fibrosis using E1-deleted adenovirus: A phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill Hum Gene Ther 5 1994 615 639
6. C.R. Brown L.Q. Hong-Brown W.J. Welch Correcting temperature-sensitive protein folding defects J Clin Invest 99 1997 1432 1444
7. S.W. Brusilow Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion Pediatr Res 29 1991 147 150
8. S.W. Brusilow J. Finkelstien Restoration of nitrogen homeostasis in a man with ornithine transcarbamylase deficiency [published erratum appears in Metabolism 43:929, 1994] Metabolism 42 1993 1336 1339
9. S. Brusilow J. Tinker M.L. Batshaw Amino acid acylation: A mechanism of nitrogen excretion in inborn errors of urea synthesis Science 207 1980 659 661
10. H.F. Cantiello Nucleotide transport through the cystic fibrosis transmembrane conductance regulator Biosci Rep 17 1997 147 171
11. V. Casavola R.J. Turner C. Guay-Broder CPX, a selective A1-adenosine-receptor antagonist, regulates intracellular pH in cystic fibrosis cells Am J Physiol 269 1995 C226 C233
12. S.H. Cheng S.L. Fang J. Zabner Functional activation of the cystic fibrosis trafficking mutant delta F508-CFTR by overexpression Am J Physiol 268 1995 L615 L624
13. B.E. Cohen G. Lee K.A. Jacobson 8-cyclopentyl-1,3-dipropylxanthine and other xanthines differentially bind to the wild-type and delta F508 first nucleotide binding fold (NBF-1) domains of the cystic fibrosis transmembrane conductance regulator Biochemistry 36 1997 6455 6461
14. A.F. Collins H.A. Pearson P. Giardina Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: A clinical trial Blood 85 1995 43 49
15. F.S. Collins Cystic fibrosis: Molecular biology and therapeutic implications Science 256 1992 774 779
16. C. Conrad S. Afione W. Guggino Administration of AAV-CFTR vectors to the airway epithelium of non-human primates is safe and efficacious [Abstract] Am J Respir Crit Care Med 149 1994 A236
17. P. Constantoulakis G. Knitter G. Stamatoyannopoulos On the induction of fetal hemoglobin by butyrates: In vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-AzaC and AraC Blood 74 1989 1963 1971
18. P. Constantoulakis G. Knitter G. Stamatoyannopoulos Butyrate stimulates HbF in adult baboons Prog Clin Biol Res 316 1989 351 361
19. W. Dalemans P. Barbry G. Champigny Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation [see comments] Nature 354 1991 526 528
20. G.M. Denning M.P. Anderson J.F. Amara Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive [see comments] Nature 358 1992 761 764
21. S. Devidas W.B. Guggino The cystic fibrosis transmembrane conductance regulator and ATP Curr Opin Cell Biol 9 1997 547 552
22. G.J. Dover S. Brusilow S. Charache Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate Blood 84 1994 339 343
23. G.J. Dover S. Brusilow D. Samid Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate [letter] N Engl J Med 327 1992 569 570
24. M.L. Drumm H.A. Pope W.H. Cliff Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer [published erratum appears in Cell 74:215, 1993] Cell 62 1990 1227 1233
25. M.E. Egan E.M. Schweibert W.B. Guggino Differential expression of ORCC and CFTR induced by low temperature in CF airway epithelial cells Am J Physiol 268 1995 C243 C251
26. O. Eidelman C. Guay-Broder P.J. van Galen A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells Proc Natl Acad Sci U S A 89 1992 5562 5566
27. K. Fearon V. McClendon B. Bonetti Premature translation termination mutations are efficiently suppressed in a highly conserved region of yeast Ste6p, a member of the ATP-binding cassette (ABC) transporter family J Biol Chem 269 1994 17802 17808
28. B.C. Freeman R.I. Morimoto The human cytosolic molecular chaperones hsp90, hsp70 (hsc70) and hdj-1 have distinct roles in recognition of a non-native protein and protein refolding EMBO J 15 1996 2969 2979
29. D.R. Gill K.W. Southern K.A. Mofford A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis Gene Ther 4 1997 199 209
30. H. Gilljam C. Stenlund A. Ericsson-Hollsing Passive smoking in cystic fibrosis Respir Med 84 1990 289 291
31. M.J. Goldman G.M. Anderson E.D. Stolzenberg Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis Cell 88 1997 553 560
32. A. Hamosh B.J. Rosenstein G.R. Cutting CFTR nonsense mutations G542X and W1282X associated with severe reduction of CFTR mRNA in nasal epithelial cells Hum Mol Genet 1 1992 542 544
33. M. Howard R.A. Frizzell D.M. Bedwell Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations [see comments] Nat Med 2 1996 467 469
34. T.C. Hwang F. Wang I.C. Yang Genistein potentiates wild-type and delta F508-CFTR channel activity Am J Physiol 273 1997 C988 C998
35. B. Illek H. Fischer T.E. Machen Alternate stimulation of apical CFTR by genistein in epithelia Am J Physiol 270 1996 C265 C275
36. B. Illek J.R. Yankaskas T.E. Machen cAMP and genistein stimulate HCO3-conductance through CFTR in human airway epithelia Am J Physiol 272 1997 L752 L761
37. I.I. Ismailov B.K. Berdiev V.G. Shlyonsky Role of actin in regulation of epithelial sodium channels by CFTR Am J Physiol 272 1997 C1077 C1086
38. K.A. Jacobson C. Guay-Broder P.J. van Galen Stimulation by alkylxanthines of chloride efflux in CFPAC-1 cells does not involve A1 adenosine receptors Biochemistry 34 1995 9088 9094
39. T.J. Jensen M.A. Loo S. Pind Multiple proteolytic systems, including the proteasome, contribute to CFTR processing Cell 83 1995 129 135
40. K.M. Jones E. Liao K. Hohneker Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis Pharmacotherapy 17 1997 263 270
41. L. Joris I. Dab P.M. Quinton Elemental composition of human airway surface fluid in healthy and diseased airways Am Rev Respir Dis 148 1993 1633 1637
42. B. Jovov I.I. Ismailov D.J. Benos Cystic fibrosis transmembrane conductance regulator is required for protein kinase A activation of an outwardly rectified anion channel purified from bovine tracheal epithelia J Biol Chem 270 1995 1521 1528
43. B. Jovov I.I. Ismailov B.K. Berdiev Interaction between cystic fibrosis transmembrane conductance regulator and outwardly rectified chloride channels J Biol Chem 270 1995 29194 29200
44. T.J. Kelley L. Al-Nakkash C.U. Cotton Activation of endogenous deltaF508 cystic fibrosis transmembrane conductance regulator by phosphodiesterase inhibition J Clin Invest 98 1996 513 520
45. T.J. Kelley L. Al-Nakkash M.L. Drumm CFTR-mediated chloride permeability is regulated by type III phosphodiesterases in airway epithelial cells Am J Respir Cell Mol Biol 13 1995 657 664
46. T.J. Kelley K. Thomas L.J. Milgram In vivo activation of the cystic fibrosis transmembrane conductance regulator mutant deltaF508 in murine nasal epithelium Proc Natl Acad Sci U S A 94 1997 2604 2608
47. E. Kerem M. Corey B.S. Kerem The relation between genotype and phenotype in cystic fibrosis— analysis of the most common mutation (delta F508) N Engl J Med 323 1990 1517 1522
48. M.R. Knowles L.L. Clarke R.C. Boucher Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis [see comments] N Engl J Med 325 1991 533 538
49. M.R. Knowles L.L. Clarke R.C. Boucher Extracellular ATP and UTP induce chloride secretion in nasal epithelia of cystic fibrosis patients and normal subjects in vivo Chest 101 1992 60S 63S
50. M.R. Knowles A.M. Paradiso R.C. Boucher In vivo nasal potential difference: Techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis Hum Gene Ther 6 1995 445 455
51. Y.H. Ko M. Delannoy P.L. Pedersen Cystic fibrosis, lung infections, and a human tracheal antimicrobial peptide (hTAP) FEBS Lett 405 1997 200 208
52. T. Kovesi M. Corey H. Levison Passive smoking and lung function in cystic fibrosis Am Rev Respir Dis 148 1993 1266 1271
53. +currents by intracellular domains of the cystic fibrosis transmembrane conductance regulator FEBS Lett 400 1997 341 344
54. J.Y. Lallemand V. Stoven J.P. Annereau Induction by antitumoral drugs of proteins that functionally complement CFTR: A novel therapy for cystic fibrosis [letter]? Lancet 350 1997 711 712
55. M.E. Levison P.G. Pitsakis P.L. May The bactericidal activity of magainins against Pseudomonas aeruginosa and Enterococcus faecium J Antimicrob Chemother 32 1993 577 585
56. C. Li M. Ramjeesingh C.E. Bear Purified cystic fibrosis transmembrane conductance regulator (CFTR) does not function as an ATP channel J Biol Chemother 271 1996 11623 11626
57. P.B. McCray Jr L. Bentley Human airway epithelia express a beta-defensin Am J Respir Cell Mol Biol 16 1997 343 349
58. K.T. McDonagh G.J. Dover R.E. Donahue Hydroxyurea-induced HbF production in anemic primates: Augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate [see comments] Exp Hematol 20 1992 1156 1164
59. S.P. Perrine G.D. Ginder D.V. Faller A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders [see comments] N Engl J Med 328 1993 81 86
60. S.P. Perrine N.F. Olivieri D.V. Faller Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders American Journal of Pediatric Hematology Oncology 16 1994 67 71
61. S. Pind J.R. Riordan D.B. Williams Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator J Biol Chem 269 1994 12784 12788
62. S.C. Piscitelli A. Thibault W.D. Figg Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine J Clin Pharmacol 35 1995 368 373
63. D.J. Porteous J.R. Dorin G. McLachlan Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis Gene Ther 4 1997 210 218
64. W.W. Reenstra K. Yurko-Mauro A. Dam CFTR chloride channel activation by genistein: the role of serine/threonine protein phosphatases Am J Physiol 271 1996 C650 C657
65. M.A. Rosenfeld F.S. Collins Gene therapy for cystic fibrosis Chest 109 1996 241 252
66. R.C. Rubenstein P.L. Zeitlin A pilot clinical trial of sodium 4-phenylbutyrate (Buphenyl) in delta F508-homozygous cystic fibrosis patients: Evidence of restoration of nasal epithelial CFTR function Am J Resp Crit Care Med 157 1997 484 490
67. R.C. Rubenstein M.E. Egan P.L. Zeitlin In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR J Clin Invest 100 1997 2457 2465
68. S. Sato C.L. Ward M.E. Krouse Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation J Biol Chem 271 1996 635 638
69. E.M. Schwiebert M.E. Egan T.H. Hwang CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP Cell 81 1995 1063 1073
70. C.L. Sears F. Firoozmand A. Mellander Genistein and tyrphostin 47 stimulate CFTR-mediated Cl-secretion in T84 cell monolayers Am J Physiol 269 1995 G874 G882
71. G.D. Sher G.D. Ginder J. Little Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies [see comments] N Engl J Med 332 1995 1606 1610
72. T. Shoshani E. Kerem A. Szeinberg Similar levels of mRNA from the W1282X and the delta F508 cystic fibrosis alleles, in nasal epithelial cells J Clin Invest 93 1994 1502 1507
73. J.J. Smith S.M. Travis E.P. Greenberg Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid [published erratum appears in Cell 87:355, 1996] Cell 85 1996 229 236
74. A. Smyth U. O'Hea G. Williams Passive smoking and impaired lung function in cystic fibrosis Arch Dis Child 71 1994 353 354
75. E. Strickland B.H. Qu L. Millen The molecular chaperone hsc70 assists the in vitro folding of the N-terminal nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator [in process citation] J Biol Chem 272 1997 25421 25424
76. J. Tatzelt S.B. Prusiner W.J. Welch Chemical chaperones interfere with the formation of scrapie prion protein EMBO J 15 1996 6363 6373
77. C.L. Ward R.R. Kopito Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins J Biol Chem 269 1994 25710 25718
78. C.L. Ward S. Omura R.R. Kopito Degradation of CFTR by the ubiquitin-proteasome pathway Cell 83 1995 121 127
79. F. Weinreich P.G. Wood J.R. Riordan Direct action of genistein on CFTR Pflugers Arch 434 1997 484 491
80. M.J. Welsh A.E. Smith J. Zabner Cystic fibrosis gene therapy using an adenovirus vector: In vivo safety and efficacy in nasal epithelium Hum Gene Ther 5 1994 209 219
81. I.C. Yang T.H. Cheng F. Wang Modulation of CFTR chloride channels by calyculin A and genistein Am J Physiol 272 1997 C142 C155
82. Y. Yang S. Janich J.A. Cohn The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment Proc Natl Acad Sci U S A 90 1993 9480 9484
83. J.W. Zhang N. Raich T. Enver Butyrate induces expression of transfected human fetal and endogenous mouse embryonic globin genes in GM 979 erythroleukemia cells Dev Genet 11 1990 168 174
84. J. Zielenski L.C. Tsui Cystic fibrosis: Genotypic and phenotypic variations Annu Rev Genet 29 1995 777 807